What is Alaunos Therapeutics, Inc. Common Stock's Market Cap?

Alaunos Therapeutics, Inc. Common Stock's Market Cap is $4.0M, based on as-reported figures from SEC (XBRL) filings.

What is Alaunos Therapeutics, Inc. Common Stock's Price / Sales?

Alaunos Therapeutics, Inc. Common Stock's Price / Sales is 1329.5×, based on as-reported figures from SEC (XBRL) filings.

What is Alaunos Therapeutics, Inc. Common Stock's Revenue (TTM)?

Alaunos Therapeutics, Inc. Common Stock's Revenue (TTM) is $3.0K, based on as-reported figures from SEC (XBRL) filings.

What is Alaunos Therapeutics, Inc. Common Stock's Net Income (TTM)?

Alaunos Therapeutics, Inc. Common Stock's Net Income (TTM) is -$4.2M, based on as-reported figures from SEC (XBRL) filings.

What is Alaunos Therapeutics, Inc. Common Stock's EBITDA?

Alaunos Therapeutics, Inc. Common Stock's EBITDA is -$4.0M, based on as-reported figures from SEC (XBRL) filings.

What is Alaunos Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Alaunos Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -1.64, based on as-reported figures from SEC (XBRL) filings.

What is Alaunos Therapeutics, Inc. Common Stock's EBITDA Margin?

Alaunos Therapeutics, Inc. Common Stock's EBITDA Margin is -134433.3%, based on as-reported figures from SEC (XBRL) filings.

Alaunos Therapeutics, Inc. Common Stock (TCRT) Financial Statements

Alaunos Therapeutics, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001SM7BJ6

XNAS · usd

1.57▼ 0.06 (-3.68%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value—

Trailing P/E—

Price / Sales

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt—

Trading Information

Previous Close1.63

Day's Range1.56 – 1.63

52-Week Range1.55 – 4.59

Volume13.9K

Avg Volume10.6K

Share Statistics

Shares Outstanding

Employees1

ExchangeXNAS

Listed2005-08-24

Share count as of August 14, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Alaunos Therapeutics, Inc. Common Stock (TCRT)

What is Alaunos Therapeutics, Inc. Common Stock's Market Cap?: Alaunos Therapeutics, Inc. Common Stock's Market Cap is $4.0M, based on as-reported figures from SEC (XBRL) filings.
What is Alaunos Therapeutics, Inc. Common Stock's Price / Sales?: Alaunos Therapeutics, Inc. Common Stock's Price / Sales is 1329.5×, based on as-reported figures from SEC (XBRL) filings.
What is Alaunos Therapeutics, Inc. Common Stock's Revenue (TTM)?: Alaunos Therapeutics, Inc. Common Stock's Revenue (TTM) is $3.0K, based on as-reported figures from SEC (XBRL) filings.
What is Alaunos Therapeutics, Inc. Common Stock's Net Income (TTM)?: Alaunos Therapeutics, Inc. Common Stock's Net Income (TTM) is -$4.2M, based on as-reported figures from SEC (XBRL) filings.
What is Alaunos Therapeutics, Inc. Common Stock's EBITDA?: Alaunos Therapeutics, Inc. Common Stock's EBITDA is -$4.0M, based on as-reported figures from SEC (XBRL) filings.
What is Alaunos Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Alaunos Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -1.64, based on as-reported figures from SEC (XBRL) filings.
What is Alaunos Therapeutics, Inc. Common Stock's EBITDA Margin?: Alaunos Therapeutics, Inc. Common Stock's EBITDA Margin is -134433.3%, based on as-reported figures from SEC (XBRL) filings.